See the technologies for hunters and anglers, from smart crossbow scopes to antler measurement tools at the Great American ...
LONDON & SEATTLE--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today ...
The gradual loss of near vision that is a natural part of aging can be addressed by glasses, contact lenses, or even surgical procedures. A presbyopia eye drop developed by Tenpoint Therapeutics now ...
Eye redness was not a commonly reported side effect in clinical trials of YUVEZZI. In BRIO I and BRIO II the reports of adverse events of ocular hyperemia (eye redness) were low. 1,2 In BRIO II, the ...
U.S. FDA Approves YUVEZZI as the only dual-agent, once daily presbyopia-correcting eye drop Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking ...
YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is the only dual-agent presbyopia-correcting eye drop intentionally designed to deliver durability, tolerability, and safety ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company, whose U.S ...
Will Sunday no longer be a peaceful day of rest for deer in the Bay State? State wildlife officials are looking into expanding deer hunting opportunities, as they gather public input on Sunday hunting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results